NCT01096082
| Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 | | treatment | 2 / 3 | completed |
NCT04714307
| Neuropsychiatry and Cognition in SCA3/MJD | No drug interventions | Not Available | Not Available | unknown_status |
NCT04419974
| Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes | No drug interventions | Not Available | Not Available | unknown_status |
NCT04229823
| Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD | No drug interventions | Not Available | Not Available | unknown_status |
NCT02906046
| Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients | No drug interventions | treatment | Not Available | completed |
NCT02039206
| The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease | No drug interventions | treatment | 2 | completed |
NCT01811706
| Dalfampridine and Gait in Spinocerebellar Ataxias | | treatment | Not Available | completed |
NCT04426149
| Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3 | No drug interventions | treatment | Not Available | completed |
NCT03120013
| Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia | No drug interventions | treatment | Not Available | completed |
NCT03408080
| Open Pilot Trial of BHV-4157 | | treatment | 3 | active_not_recruiting |
NCT03487367
| Clinical Trial Readiness for SCA1 and SCA3 | No drug interventions | Not Available | Not Available | unknown_status |
NCT04153110
| Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia | No drug interventions | treatment | Not Available | completed |
NCT02175290
| Machado-Joseph Disease in Israel | No drug interventions | Not Available | Not Available | unknown_status |
NCT01793168
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford | No drug interventions | Not Available | Not Available | recruiting |
NCT02147886
| Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease | | treatment | 2 | completed |
NCT04268147
| Instrumented Data Exchange for Ataxia Study | No drug interventions | Not Available | Not Available | completed |
NCT05826171
| Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia | No drug interventions | treatment | Not Available | active_not_recruiting |
NCT05502432
| Repetitive Transcranial Magnetic Stimulation in SCA3 Patients | No drug interventions | treatment | Not Available | completed |
NCT03701399
| Troriluzole in Adult Subjects With Spinocerebellar Ataxia | | treatment | 3 | active_not_recruiting |
NCT05490563
| STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia | No drug interventions | treatment | 2 / 3 | terminated |
NCT05557786
| Treatment of Transcranial Alternating Current Stimulation(tACS)on Cerebellar Ataxia | No drug interventions | treatment | Not Available | completed |
NCT04399265
| Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3 | No drug interventions | treatment | Not Available | unknown_status |
NCT03885167
| Identification of Biomarkers in Spinocerebellar Ataxia 3 | No drug interventions | Not Available | Not Available | completed |
NCT05822908
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD | | treatment | 1 / 2 | recruiting |
NCT04301284
| Study of CAD-1883 for Spinocerebellar Ataxia | | treatment | 2 | withdrawn |
NCT01060371
| Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias | No drug interventions | Not Available | Not Available | recruiting |
NCT00992771
| Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3 | | treatment | 2 | completed |
NCT05160558
| A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 | No drug interventions | treatment | 1 | terminated |
NCT01096095
| Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 | | treatment | 2 | withdrawn |
NCT03378414
| Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia | No drug interventions | treatment | 2 | not_yet_recruiting |